228422-71-7

Upstream product

• 58955-10-5 4-fluoro-3-nitrobenzanilide 

Downstream Products

• 228422-72-8 3-amino-4-ethoxy-N-phenyl-benzamide 
• 228422-81-9 3-Amino-4-methylsulfanyl-N-phenyl-benzamide 
• 50516-77-3 N-(3-amino-4-methoxyphenyl)-benzamide 
• 167993-22-8 benzyl 3-amino-4-methoxybenzoate 

Relevant academic research and scientific papers

Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compostions containing them

Compounds of formula (I): wherein: RCy represents an unsubstituted or substituted cycloalkyl group or cycloalkylalkyl group,R1, R2, R3 and R4, which may be the same or different, each represent a hydrogen or halogen atom or a nitro group; a cyano group; a hydroxy group; an alkoxy group; an alkyl group; an unsubstituted or substituted amino group; a carboxy group; an alkoxycarbonyl group; an aryloxycarbonyl group; an unsubstituted or substituted aminocarbonyl group. Medicinal products containing the same which are useful in treating or preventing conditions treatable by an AMPA receptor modulator.

Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis

The present invention provides compounds of formula (I). The present invention also provides methods of treating or preventing inflammation or atherosclerosis, and a pharmaceutical composition that contains a compound of formula (I).